FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR

NCT00810030 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

484

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammatory Bowel Disease
Anemia
Iron Deficiency
Iron-Deficiency Anemia
Crohn's Disease
Ulcerative Colitis

Interventions

DRUG: Ferric carboxymaltose
DRUG: Iron Sucrose

Sponsor

Vifor Pharma

Collaborators

[object Object]
[object Object]